
Sign up to save your podcasts
Or


Professor Stephen Johnston from The Royal Marsden NHS Foundation Trust and The Institute of Cancer Research in London discusses the role of CDK4/6 inhibitors in adjuvant therapy for ER-positive breast cancer.
CME information and select publications here.
By Research To Practice5
66 ratings
Professor Stephen Johnston from The Royal Marsden NHS Foundation Trust and The Institute of Cancer Research in London discusses the role of CDK4/6 inhibitors in adjuvant therapy for ER-positive breast cancer.
CME information and select publications here.

66 Listeners

30 Listeners

75 Listeners

14 Listeners

17 Listeners

4 Listeners

2 Listeners

12 Listeners

0 Listeners

122 Listeners